Daniel D. Buchanan

23.1k total citations
181 papers, 6.2k citations indexed

About

Daniel D. Buchanan is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Daniel D. Buchanan has authored 181 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Pathology and Forensic Medicine, 86 papers in Oncology and 51 papers in Cancer Research. Recurrent topics in Daniel D. Buchanan's work include Genetic factors in colorectal cancer (113 papers), Colorectal Cancer Screening and Detection (68 papers) and Cancer Genomics and Diagnostics (45 papers). Daniel D. Buchanan is often cited by papers focused on Genetic factors in colorectal cancer (113 papers), Colorectal Cancer Screening and Detection (68 papers) and Cancer Genomics and Diagnostics (45 papers). Daniel D. Buchanan collaborates with scholars based in Australia, United States and Canada. Daniel D. Buchanan's co-authors include Joanne Young, Mark A. Jenkins, John L. Hopper, Aung Ko Win, Polly A. Newcomb, Christophe Rosty, Mark Clendenning, John A. Baron, John D. Potter and Amanda B. Spurdle and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Daniel D. Buchanan

173 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel D. Buchanan Australia	45	3.1k	3.0k	2.0k	1.5k	728	181	6.2k
Guglielmina Nadia Ranzani Italy	31	3.9k 1.3×	3.4k 1.1×	1.9k 1.0×	1.9k 1.3×	775 1.1×	97	6.5k
Constance A. Griffin United States	47	1.3k 0.4×	3.2k 1.1×	3.2k 1.6×	1.7k 1.1×	1.3k 1.9×	140	8.8k
Carl Morrison United States	45	922 0.3×	2.3k 0.8×	4.2k 2.1×	2.4k 1.5×	1.3k 1.8×	185	8.1k
Kefah Mokbel United Kingdom	44	1.3k 0.4×	1.6k 0.5×	2.1k 1.0×	2.2k 1.4×	480 0.7×	307	6.3k
Anne‐Marie Gerdes Denmark	41	991 0.3×	1.1k 0.4×	1.8k 0.9×	944 0.6×	387 0.5×	168	4.7k
Takuya Moriya Japan	52	995 0.3×	2.7k 0.9×	3.1k 1.5×	1.7k 1.1×	1.6k 2.2×	336	9.3k
Matthew D. Ringel United States	55	770 0.3×	2.1k 0.7×	3.6k 1.8×	1.2k 0.8×	612 0.8×	176	9.1k
Elena M. Stoffel United States	38	2.4k 0.8×	2.7k 0.9×	854 0.4×	1.4k 0.9×	766 1.1×	137	4.7k
Leandro Cerchietti United States	42	1.0k 0.3×	1.6k 0.5×	2.9k 1.5×	725 0.5×	539 0.7×	132	5.4k
Wenyi Wang United States	34	764 0.2×	1.7k 0.6×	1.8k 0.9×	1.1k 0.7×	614 0.8×	146	5.0k

Countries citing papers authored by Daniel D. Buchanan

Since Specialization

Citations

This map shows the geographic impact of Daniel D. Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Buchanan more than expected).

Fields of papers citing papers by Daniel D. Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Buchanan. The network helps show where Daniel D. Buchanan may publish in the future.

Co-authorship network of co-authors of Daniel D. Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Buchanan. A scholar is included among the top collaborators of Daniel D. Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Buchanan. Daniel D. Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Møller, Pål, Aysel Ahadova, Matthias Kloor, et al.. (2025). Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequences. Hereditary Cancer in Clinical Practice. 23(1). 3–3. 1 indexed citations

Thomas, Claire E., Yasutoshi Takashima, Daniel D. Buchanan, et al.. (2025). Density of T-cell Subsets in Colorectal Cancer in Relation to Disease-Specific Survival. Cancer Epidemiology Biomarkers & Prevention. 34(7). 1122–1133. 1 indexed citations

Prizment, Anna E., Conghui Qu, Shuo Wang, et al.. (2025). Functional variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene are associated with increased risk of colorectal cancer. Human Molecular Genetics. 34(7). 617–625. 1 indexed citations

Mouradov, Dmitri, Paul Greenfield, Shan Li, et al.. (2023). Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer. Gastroenterology. 165(1). 104–120. 53 indexed citations

Dugué, Pierre‐Antoine, Chenglong Yu, Allison Hodge, et al.. (2023). Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer. International Journal of Cancer. 153(3). 489–498. 7 indexed citations

Lai, John, Daniel F. Schmidt, Robert J. MacInnis, et al.. (2023). Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility Loci. Cancer Epidemiology Biomarkers & Prevention. 32(9). 1153–1159.

Bakshi, Andrew, Yin Cao, Suzanne G. Orchard, et al.. (2022). Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older Individuals. Cancer Prevention Research. 15(7). 447–454. 3 indexed citations

Lu, Yujia, Yu Zhao, Jenny Chang‐Claude, et al.. (2022). Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis. Cancer Epidemiology Biomarkers & Prevention. 32(2). 281–286. 3 indexed citations

Currey, Nicola, Mark A. Jenkins, Daniel D. Buchanan, et al.. (2021). Tetranucleotide and Low Microsatellite Instability Are Inversely Associated with the CpG Island Methylator Phenotype in Colorectal Cancer. Cancers. 13(14). 3529–3529. 5 indexed citations

10.

Matejcic, Marco, Melanie Quintana, Fredrick R. Schumacher, et al.. (2021). Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention. 30(5). 895–903. 4 indexed citations

11.

Dugué, Pierre‐Antoine, Julie K. Bassett, Ee Ming Wong, et al.. (2020). Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study. JNCI Cancer Spectrum. 5(1). 47 indexed citations

12.

Parry, Susan, Randall W. Burt, Aung Ko Win, et al.. (2017). Reducing the polyp burden in serrated polyposis by serial colonoscopy: the impact of nationally coordinated community surveillance.. PubMed. 130(1451). 57–67. 11 indexed citations

13.

Wang, Fan, Robert W. Rapkins, Robyn L. Ward, et al.. (2016). SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT -Methylated Colorectal Cancer. Clinical Cancer Research. 22(24). 6266–6277. 20 indexed citations

14.

Hardikar, Sheetal, Polly A. Newcomb, Peter T. Campbell, et al.. (2015). Prediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics. Cancer Epidemiology Biomarkers & Prevention. 24(7). 1130–1137. 30 indexed citations

15.

Win, Aung Ko, James G. Dowty, Daniel D. Buchanan, et al.. (2015). 1054 Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. European Journal of Cancer. 51. S163–S163. 9 indexed citations

16.

Mouradov, Dmitri, Clare Sloggett, Robert N. Jorissen, et al.. (2014). Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer. Cancer Research. 74(12). 3238–3247. 287 indexed citations

17.

Walsh, Michael D., Mark Clendenning, Elizabeth Williamson, et al.. (2013). Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Modern Pathology. 26(12). 1642–1656. 122 indexed citations

18.

Phipps, Amanda I., Daniel D. Buchanan, Karen W. Makar, et al.. (2012). BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics. Cancer Epidemiology Biomarkers & Prevention. 21(10). 1792–1798. 97 indexed citations

19.

Cicek, Mine, Noralane M. Lindor, Steven Gallinger, et al.. (2011). Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors. Journal of Molecular Diagnostics. 13(3). 271–281. 113 indexed citations

20.

Siegmund, Kimberly D., Mihaela Campan, Joanne Young, et al.. (2006). CpG Island Methylator Phenotype in Human Colorectal Cancer Is Tightly Associated with BRAF Mutation and Underlies Sporadic Mismatch Repair Deficiency.. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact